Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics.

Saliba J, Kasim NR, Tamboli RA, Isbell JM, Marks P, Feurer ID, Ikizler A, Abumrad NN.

Surgery. 2010 Feb;147(2):282-7. doi: 10.1016/j.surg.2009.09.017. Epub 2009 Dec 11.

2.

Renal glomerular and tubular injury after gastric bypass in obese rats.

Canales BK, Reyes L, Reinhard MK, Khan SR, Goncalves CG, Meguid MM.

Nutrition. 2012 Jan;28(1):76-80. doi: 10.1016/j.nut.2011.03.003. Epub 2011 Jul 1.

4.

Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.

Serpa Neto A, Bianco Rossi FM, Dal Moro Amarante R, Alves Buriti N, Cunha Barbosa Saheb G, Rossi M.

J Nephrol. 2009 Sep-Oct;22(5):637-46.

PMID:
19809997
5.

The effect of the non-ionic contrast medium iohexol on glomerular and tubular function in diabetic patients.

Apelqvist J, Torffvit O, Agardh CD.

Diabet Med. 1996 May;13(5):487-92.

PMID:
8737033
6.

Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.

Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, Ikramuddin S.

J Surg Res. 2007 Jul;141(1):31-9.

PMID:
17574036
7.

Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.

Nasr SH, D'Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, Markowitz GS.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1676-83. doi: 10.2215/CJN.02940608. Epub 2008 Aug 13.

8.

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Bojsen-Møller KN.

Dan Med J. 2015 Apr;62(4):B5057. Review.

PMID:
25872541
9.

Nitrosative stress but not glycemic parameters correlate with improved neuropathy in nonseverely obese diabetic patients after Roux-Y gastric bypass.

Müller-Stich BP, Billeter AT, Fleming T, Fischer L, Büchler MW, Nawroth PP.

Surg Obes Relat Dis. 2015 Jul-Aug;11(4):847-54. doi: 10.1016/j.soard.2014.12.007. Epub 2014 Dec 16.

PMID:
25862183
10.

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, Lindqvist Hansen D, Madsbad S, Holst JJ.

Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E122-31. doi: 10.1152/ajpendo.00073.2012. Epub 2012 Apr 24.

PMID:
22535748
11.

Changes in renal function following Roux-en-Y gastric bypass: a prospective study.

Getty JL, Hamdallah IN, Shamseddeen HN, Wu J, Low RK, Craig J, Ali MR.

Obes Surg. 2012 Jul;22(7):1055-9. doi: 10.1007/s11695-012-0617-0.

PMID:
22318447
12.

Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.

Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, Ikramuddin S.

J Surg Res. 2007 Oct;142(2):295-300. Epub 2007 Jul 19.

PMID:
17640666
13.

Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.

Reed MA, Pories WJ, Chapman W, Pender J, Bowden R, Barakat H, Gavin TP, Green T, Tapscott E, Zheng D, Shankley N, Yieh L, Polidori D, Piccoli SP, Brenner-Gati L, Dohm GL.

J Clin Endocrinol Metab. 2011 Aug;96(8):2525-31. doi: 10.1210/jc.2011-0165. Epub 2011 May 18.

PMID:
21593117
14.

Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study.

Campos GM, Rabl C, Roll GR, Peeva S, Prado K, Smith J, Vittinghoff E.

Arch Surg. 2011 Feb;146(2):149-55. doi: 10.1001/archsurg.2010.316.

PMID:
21339424
15.

Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study.

Fenske WK, Dubb S, Bueter M, Seyfried F, Patel K, Tam FW, Frankel AH, le Roux CW.

Surg Obes Relat Dis. 2013 Jul-Aug;9(4):559-68. doi: 10.1016/j.soard.2012.03.009. Epub 2012 Apr 10.

PMID:
22608055
16.

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.

Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.

Surg Obes Relat Dis. 2009 May-Jun;5(3):305-9. doi: 10.1016/j.soard.2009.02.007. Epub 2009 Feb 26.

PMID:
19460674
17.

Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects.

Lips MA, Pijl H, van Klinken JB, de Groot GH, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Smit JW.

Eur J Endocrinol. 2013 Aug 28;169(3):339-47. doi: 10.1530/EJE-13-0339. Print 2013 Sep.

18.

Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy.

Bayham BE, Greenway FL, Bellanger DE, O'Neil CE.

Diabetes Technol Ther. 2012 Jan;14(1):30-4. doi: 10.1089/dia.2011.0151. Epub 2011 Sep 20.

PMID:
21933001
19.

Monitoring renal function in obese patients with type 2 diabetes mellitus in daily practice.

van de Ree MA, Christiaan G, Huisman MV, van der Vijver JC, Meinders AE.

Diabetes Nutr Metab. 2001 Apr;14(2):66-70.

PMID:
11383675
20.

Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.

Pinheiro JS, Schiavon CA, Pereira PB, Correa JL, Noujaim P, Cohen R.

Surg Obes Relat Dis. 2008 Jul-Aug;4(4):521-5; discussion 526-7. doi: 10.1016/j.soard.2007.12.016. Epub 2008 Jun 9.

PMID:
18539540

Supplemental Content

Support Center